LYFT vs VRTX · P/E 108, rev $5.79B vs P/E 30, rev $12.00B
LYFT Inc (LYFT) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
LYFT currently screens at market cap $6.79B and trailing P/E 107.7. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the LYFT and VRTX stock pages for the full models.
Not investment advice.